Annotation Detail for TTLL4

 Basic Information 
Top
        	
        			| Chemical ID | Chemical Name | Interaction | Interaction Action | Publication | 
|---|
| D016572 | Cyclosporine | Cyclosporine results in increased expression of TTLL4 mRNA | increases expression | 20106945 
 | 
| C013038 | hydroxyhydroquinone | hydroxyhydroquinone results in increased expression of TTLL4 mRNA | increases expression | 17572062 
 | 
| C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of TTLL4 mRNA | affects binding|increases activity|increases expression | 19710929 
 | 
| C017947 | sodium arsenite | sodium arsenite affects the expression of TTLL4 mRNA | affects expression | 19590694 
 | 
| Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication | 
|---|
| MESH:D055371 | Acute Lung Injury |  | pirinixic acid | 3.58 | 18653653 | 
| MESH:D018248 | Adenoma, Liver Cell |  | pirinixic acid | 4.11 | 16434500 | 
| MESH:D000310 | Adrenal Gland Neoplasms |  | sodium arsenite | 5.42 | 15276417 | 
| MESH:D018246 | Adrenocortical Adenoma |  | sodium arsenite | 5.63 | 17306315	16712894 | 
| MESH:D001778 | Blood Coagulation Disorders |  | pirinixic acid | 3.57 | 19483382 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | sodium arsenite | 2.01 | 16507464	17306315	15276417 | 
| MESH:D002294 | Carcinoma, Squamous Cell |  | sodium arsenite | 2.46 | 18572023 | 
| MESH:D002471 | Cell Transformation, Neoplastic |  | Cyclosporine | 7.54 | 12371664 | 
| MESH:D002471 | Cell Transformation, Neoplastic |  | sodium arsenite | 7.54 | 20056578	19524636 | 
| MESH:D002779 | Cholestasis |  | Cyclosporine | 8.74 | 19486331 | 
| MESH:D002779 | Cholestasis |  | pirinixic acid | 8.74 | 19176532 | 
| MESH:D003876 | Dermatitis, Atopic |  | pirinixic acid | 2.57 | 18249437 | 
| MESH:D004487 | Edema |  | pirinixic acid | 2.90 | 12083418 | 
| MESH:D005234 | Fatty Liver |  | Cyclosporine | 9.01 | 19224547 | 
| MESH:D005234 | Fatty Liver |  | pirinixic acid | 9.01 | 20131406	19236843 | 
| MESH:D005355 | Fibrosis |  | Cyclosporine | 3.70 | 12639820	12168785 | 
| MESH:D005833 | Genital Neoplasms, Female |  | sodium arsenite | 5.31 | 16452187 | 
| MESH:D005885 | Gingival Hyperplasia |  | Cyclosporine | 4.85 | 8708960 | 
| MESH:D006333 | Heart Failure |  | pirinixic acid | 2.76 | 20558911 | 
| MESH:D006457 | Hemoglobinuria, Paroxysmal |  | Cyclosporine | 5.05 | 15720958 | 
| MESH:D006529 | Hepatomegaly |  | pirinixic acid | 3.55 | 19176532	19772884	18467677	16221962 | 
| MESH:D006689 | Hodgkin Disease |  | sodium arsenite | 3.52 | 12676792 | 
| MESH:D006943 | Hyperglycemia |  | pirinixic acid | 3.58 | 20558911 | 
| MESH:D006973 | Hypertension |  | Cyclosporine | 2.21 | 10903974 | 
| MESH:D007248 | Infertility, Male |  | sodium arsenite | 3.24 | 15346721	12646999 | 
| MESH:D007333 | Insulin Resistance |  | pirinixic acid | 2.87 | 16306350 | 
| MESH:D007638 | Keratoconjunctivitis Sicca |  | Cyclosporine | 5.16 | 15604871 | 
| MESH:D007674 | Kidney Diseases |  | Cyclosporine | 6.70 | 8314463	10903974	18776723 | 
| MESH:D007674 | Kidney Diseases |  | sodium arsenite | 6.70 | 20008137 | 
| MESH:D007680 | Kidney Neoplasms |  | Cyclosporine | 3.08 | 12371664 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | pirinixic acid | 1.35 | 15474484 | 
| MESH:D008113 | Liver Neoplasms |  | pirinixic acid | 4.89 | 20007298	16377806	15890375 | 
| MESH:D008113 | Liver Neoplasms |  | sodium arsenite | 4.89 | 16712894	15276417 | 
| MESH:D008171 | Lung Diseases |  | sodium arsenite | 3.42 | 19095001 | 
| MESH:D008175 | Lung Neoplasms |  | sodium arsenite | 1.90 | 15276417	16712894	17077188	17306315	19931552 | 
| MESH:D008545 | Melanoma |  | sodium arsenite | 2.07 | 16487513	19082730 | 
| MESH:D008664 | Metal Metabolism, Inborn Errors |  | Cyclosporine | 5.51 | 16801185 | 
| MESH:D009135 | Muscular Diseases |  | pirinixic acid | 4.07 | 16239165 | 
| MESH:D009203 | Myocardial Infarction |  | pirinixic acid | 2.27 | 19151258 | 
| MESH:D015428 | Myocardial Reperfusion Injury |  | pirinixic acid | 3.25 | 16411023 | 
| MESH:D009369 | Neoplasms |  | pirinixic acid | 5.51 | 17405874 | 
| MESH:D009369 | Neoplasms |  | sodium arsenite | 5.51 | 11559025 | 
| MESH:D009374 | Neoplasms, Experimental |  | sodium arsenite | 4.22 | 20056578 | 
| MESH:D009402 | Nephrosis, Lipoid |  | Cyclosporine | 5.16 | 17954296 | 
| MESH:D009404 | Nephrotic Syndrome |  | Cyclosporine | 3.65 | 18481113	19348381 | 
| MESH:D009436 | Neural Tube Defects |  | sodium arsenite | 3.38 | 12854658 | 
| MESH:D009765 | Obesity |  | pirinixic acid | 1.88 | 20558911 | 
| MESH:D010051 | Ovarian Neoplasms |  | sodium arsenite | 2.53 | 15276417	17306315 | 
| MESH:D011230 | Precancerous Conditions |  | Cyclosporine | 3.59 | 12371664 | 
| MESH:D011471 | Prostatic Neoplasms |  | sodium arsenite | 3.24 | 16039940 | 
| MESH:D011565 | Psoriasis |  | Cyclosporine | 2.33 | 16882103 | 
| MESH:D015427 | Reperfusion Injury |  | pirinixic acid | 2.55 | 19058328 | 
| MESH:D012878 | Skin Neoplasms |  | sodium arsenite | 2.85 | 19524636	18572023 | 
| MESH:D016135 | Spinal Dysraphism |  | sodium arsenite | 4.10 | 12854658 | 
| MESH:D001749 | Urinary Bladder Neoplasms |  | sodium arsenite | 2.63 | 11723127	16452187	16712894	17306315 | 
| MESH:D002583 | Uterine Cervical Neoplasms |  | sodium arsenite | 4.16 | 11813266 | 
| MESH:D014605 | Uveitis |  | Cyclosporine | 4.71 | 1336536 | 
| MESH:D014652 | Vascular Diseases |  | sodium arsenite | 5.06 | 17056641 | 
| MESH:D014985 | Xerophthalmia |  | Cyclosporine | 5.16 | 17120751 |